NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









GenePlanet

GenePlanet

Private
LjubljanaHealthcare & Life Scienceshttps://geneplanet.com/

Last Round

Series B

Jul 13, 2023

Total Funding Raised

$22.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

GenePlanet is a biotechnology company that is a provider of innovative healthcare and lifestyle solutions based on preventive genetic testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, D2C Brands, InsurTech

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS, Freemium

AI Layer

Application

Keywords

genetic testingat-home DNA testpreventative healthcarepersonalized healthbiotechnologydigital health platformwhole genome sequencingWGSnon-invasive prenatal testingNIPTprecision medicinecorporate wellnessinsurtech solutionspharmacogenomicscancer genetic screeninggenomic AImicrobiome test

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenePlanet Comparables

Compare GenePlanet with similar companies based on industry and business-model similarity.

GenePlanet comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dante Labs
81%
LetsGetChecked
78%
Prenetics
76%

GenePlanet Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 13, 2023
VC RoundJul 9, 2018

Key People

Founding team and executive leadership

Marko Bitenc

Founder And CEO

Founding Team

GenePlanet Investors

Notable investors and investment history

GenePlanet investors
InvestorRounds
Designed Impact VenturesSeries B
BlackPeak CapitalSeries B
FMR d.o.o.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open roles increased to 96, 57% of headcount.

  • Jan 20, 2026

    Monthly visitors increased 33% MoM.

GenePlanet Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GenePlanet Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenePlanet's valuation, stock price, and market status.

Firmographic Details

HeadquartersLjubljana
Employee Range168
Year Founded2008
Last FundingJul 13, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.